Implicity’s Heart Failure Algorithm Gains FDA 510(k) Approval

The SignalHF1 system can predict the likelihood of subsequent cardiac failure episodes, which allows doctors to intervene early to avoid hospital stays.

Implicity CEO and cardiologist stated: “Heart failure remains a significant healthcare challenge, contributing to approximately one million hospitalisations each year. Preventing even a portion of these would be a game-changer in cardiac care.

“SignalHF is an innovative and effective tool that physicians can use to assess the risk of hospitalisation due to heart failure earlier, enabling interventions that can lead to better outcomes and reduce hospital admissions.”

If an individual’s risk score rises over a specific level, the algorithm instantly notifies care workers, signalling a significant possibility of impending cardiac failure and possible hospitalisation.

Implicity data head explained: “Comprehensive heart failure management includes treatment, prevention, and personalisation. Implicity’s solution is part of this approach. Our alerts are generated in context with a patient’s medical profile to help personalise care management plans.

“Furthermore, 75% of the alerts preceding a patient hospitalisation are sent at least 14 days in advance – offering a two-week window to adjust medications or take proactive measures.”